$2.5T
Total marketcap
$67.46B
Total volume
BTC 50.17%     ETH 16.13%
Dominance

Cytek Biosciences CTKB Stock

6.17 USD {{ price }} -2.063494% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
807.18M USD
LOW - HIGH [24H]
6.12 - 6.25 USD
VOLUME [24H]
465.54K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.09 USD

Cytek Biosciences Price Chart

Cytek Biosciences CTKB Financial and Trading Overview

Cytek Biosciences stock price 6.17 USD
Previous Close 8.38 USD
Open 8.32 USD
Bid 0 USD x 900
Ask 0 USD x 800
Day's Range 8.32 - 8.74 USD
52 Week Range 6.45 - 16.05 USD
Volume 919.76K USD
Avg. Volume 1.36M USD
Market Cap 1.18B USD
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) -0.09 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 14.25 USD

CTKB Valuation Measures

Enterprise Value 855.15M USD
Trailing P/E N/A
Forward P/E 28
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 7.09135
Price/Book (mrq) 2.7802691
Enterprise Value/Revenue 5.15
Enterprise Value/EBITDA -115.405

Trading Information

Cytek Biosciences Stock Price History

Beta (5Y Monthly) N/A
52-Week Change -12.58%
S&P500 52-Week Change 20.43%
52 Week High 16.05 USD
52 Week Low 6.45 USD
50-Day Moving Average 9.13 USD
200-Day Moving Average 11.45 USD

CTKB Share Statistics

Avg. Volume (3 month) 1.36M USD
Avg. Daily Volume (10-Days) 721.54K USD
Shares Outstanding 135.67M
Float 91.5M
Short Ratio 5.47
% Held by Insiders 17.06%
% Held by Institutions 55.10%
Shares Short 8.68M
Short % of Float 7.24%
Short % of Shares Outstanding 6.40%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -1.44%
Operating Margin (ttm) -6.087%
Gross Margin 61.32%
EBITDA Margin -4.46%

Management Effectiveness

Return on Assets (ttm) -1.25%
Return on Equity (ttm) -0.52%

Income Statement

Revenue (ttm) 166.06M USD
Revenue Per Share (ttm) 1.23 USD
Quarterly Revenue Growth (yoy) 5.80%
Gross Profit (ttm) 100.97M USD
EBITDA -7410000 USD
Net Income Avi to Common (ttm) -2394000 USD
Diluted EPS (ttm) -0.01
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 299M USD
Total Cash Per Share (mrq) 2.2 USD
Total Debt (mrq) 17.26M USD
Total Debt/Equity (mrq) 4.08 USD
Current Ratio (mrq) 7.531
Book Value Per Share (mrq) 3.122

Cash Flow Statement

Operating Cash Flow (ttm) -7893000 USD
Levered Free Cash Flow (ttm) -31802124 USD

Profile of Cytek Biosciences

Country United States
State CA
City Fremont
Address 47215 Lakeview Boulevard
ZIP 94538
Phone 877 922 9835
Website https://cytekbio.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 682

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Q&A For Cytek Biosciences Stock

What is a current CTKB stock price?

Cytek Biosciences CTKB stock price today per share is 6.17 USD.

How to purchase Cytek Biosciences stock?

You can buy CTKB shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Cytek Biosciences?

The stock symbol or ticker of Cytek Biosciences is CTKB.

Which industry does the Cytek Biosciences company belong to?

The Cytek Biosciences industry is Medical Devices.

How many shares does Cytek Biosciences have in circulation?

The max supply of Cytek Biosciences shares is 130.82M.

What is Cytek Biosciences Price to Earnings Ratio (PE Ratio)?

Cytek Biosciences PE Ratio is now.

What was Cytek Biosciences earnings per share over the trailing 12 months (TTM)?

Cytek Biosciences EPS is -0.09 USD over the trailing 12 months.

Which sector does the Cytek Biosciences company belong to?

The Cytek Biosciences sector is Healthcare.

Cytek Biosciences CTKB included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16175.09 USD
-1.62
3.94B USD 16125.33 USD 16341.46 USD 3.94B USD
NASDAQ Global Select Market Com NQGS 7876.03 USD
-1.61
7852.08 USD 7955.84 USD
Nasdaq US 700 Small Cap Index NQUS700SC 2060.1 USD
-1.99
2051.95 USD 2093.4 USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2541.54 USD
-1.89
2531.95 USD 2572.66 USD
NASDAQ HealthCare IXHC 958.68 USD
-2.07
954.08 USD 972.42 USD